Biomarin Pharmaceutical Inc (BMRN)
71.44
-1.39
(-1.91%)
USD |
NASDAQ |
Mar 28, 16:00
71.39
-0.05
(-0.07%)
After-Hours: 20:00
Biomarin Pharmaceutical Market Cap: 13.63B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna Inc | 12.03B |
| Pfizer Inc | 142.87B |
| Alnylam Pharmaceuticals Inc | 34.75B |
| Gilead Sciences Inc | 139.22B |
| Sarepta Therapeutics Inc | 6.832B |
Market Cap Related Metrics
| PE Ratio | 32.47 |
| PS Ratio | 4.967 |
| PEG Ratio | 0.2165 |
| Price to Book Value | 2.409 |
| Price to Free Cash Flow | 29.82 |
| Price | 71.44 |
| Earnings Yield | 3.08% |
| PEGY Ratio | 0.2165 |
| Operating PE Ratio | 29.90 |
| Normalized PE Ratio | 33.11 |